209 related articles for article (PubMed ID: 19231637)
21. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
22. Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature.
Kao GF; Resh B; McMahon C; Gojo I; Sun CC; Phillips D; Zhao XF
Am J Dermatopathol; 2008 Dec; 30(6):593-9. PubMed ID: 19033937
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].
Humme D; Möbs M; Pullmann S; Haidar A; Beyer M; Sterry W; Assaf C
Hautarzt; 2012 May; 63(5):423-35; quiz 436. PubMed ID: 22527299
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous T-cell lymphoid dyscrasia: a unifying term for idiopathic chronic dermatoses with persistent T-cell clones.
Guitart J; Magro C
Arch Dermatol; 2007 Jul; 143(7):921-32. PubMed ID: 17638739
[TBL] [Abstract][Full Text] [Related]
25. Sezary syndrome: a case study of cutaneous T-cell lymphoma.
Crandon S; Yancey MA
Clin J Oncol Nurs; 2009 Apr; 13(2):157-9. PubMed ID: 19349262
[No Abstract] [Full Text] [Related]
26. Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?
Dummer R; Assaf C; Bagot M; Gniadecki R; Hauschild A; Knobler R; Ranki A; Stadler R; Whittaker S
Eur J Cancer; 2007 Nov; 43(16):2321-9. PubMed ID: 17707638
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous lymphomas.
Dummer R; Stadler R; Sterry W
J Dtsch Dermatol Ges; 2007 Jul; 5(7):605-17. PubMed ID: 17610612
[TBL] [Abstract][Full Text] [Related]
28. Disparities in Cutaneous T-Cell Lymphoma Incidence by Race/Ethnicity and Area-Based Socioeconomic Status.
Wiese D; Stroup AM; Shevchenko A; Hsu S; Henry KA
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834276
[TBL] [Abstract][Full Text] [Related]
29. T/natural killer-cell lymphoma of the testis with cutaneous and subcutaneous soft tissue involvement: a management problem.
Morelli L; Piscioli I; Licci S; Del Nonno F; Neri M; Sabattini E
Ann Hematol; 2007 Jun; 86(6):469-70. PubMed ID: 17446989
[No Abstract] [Full Text] [Related]
30. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases.
Beltraminelli H; Leinweber B; Kerl H; Cerroni L
Am J Dermatopathol; 2009 Jun; 31(4):317-22. PubMed ID: 19461234
[TBL] [Abstract][Full Text] [Related]
31. Arthritis mutilans associated with cutaneous T cell lymphoma.
Mathur A; Parhami N
J Rheumatol; 1992 Sep; 19(9):1489-90. PubMed ID: 1433027
[No Abstract] [Full Text] [Related]
32. Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy.
Becker JC; Kauczok CS; Ugurel S; Eib S; Bröcker EB; Houben R
J Dtsch Dermatol Ges; 2008 Sep; 6(9):709-19. PubMed ID: 19000060
[TBL] [Abstract][Full Text] [Related]
33. Molecular identity of skin and blood T-cell clones in cutaneous T-cell lymphoma patients as determined from the migration pattern of the T-cell receptor-gamma gene by capillary electrophoresis.
Gubler B; Marty-Grès S; Guillot B; Eliaou JF; Dereure O
Electrophoresis; 2009 Mar; 30(6):999-1007. PubMed ID: 19309017
[TBL] [Abstract][Full Text] [Related]
34. Introduction: cutaneous T-cell lymphoma (CTCL)--classification, staging, and treatment options.
Bagot M
Dermatol Clin; 2008 Jan; 26 Suppl 1():3-12. PubMed ID: 18405180
[No Abstract] [Full Text] [Related]
35. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature.
Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE
J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic eosinophilia.
Guitart J
N Engl J Med; 2000 Mar; 342(9):659-60; author reply 660-1. PubMed ID: 10702057
[No Abstract] [Full Text] [Related]
37. Eczematous malignant melanoma: a wolf in sheep's clothing.
Mensing C; Livingstone E; Schwarz T; Hauschild A
Onkologie; 2009 Apr; 32(4):206-8. PubMed ID: 19372718
[TBL] [Abstract][Full Text] [Related]
38. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
[TBL] [Abstract][Full Text] [Related]
39. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
40. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color.
McKenzie S; Brown-Korsah JB; Syder NC; Omar D; Taylor SC; Elbuluk N
J Am Acad Dermatol; 2022 Dec; 87(6):1261-1270. PubMed ID: 35817332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
